| Literature DB >> 35422859 |
Hilmi Farhan Ramadhani1, Annisa Annisa1, Aryo Tedjo2, Dimas R Noor3, Wisnu Ananta Kusuma1,4.
Abstract
Introduction: The severity of coronavirus disease 2019 (COVID-19) was known to be affected by hyperinflammation. Identification of important proteins associated with hyperinflammation is critical. These proteins can be a potential target either as biomarkers or targets in drug discovery. Therefore, we combined enrichment analysis of these proteins to identify biological knowledge related to hyperinflammation. Moreover, we conducted transcriptomic data analysis to reveal genes contributing to disease severity.Entities:
Year: 2022 PMID: 35422859 PMCID: PMC9002903 DOI: 10.1155/2022/3515001
Source DB: PubMed Journal: Interdiscip Perspect Infect Dis ISSN: 1687-708X
Figure 1Illustration of three aspects in GO.
Figure 2Illustration of three bipartite graph.
Figure 3Matrix illustration on fuzzy K-partite clustering algorithm.
Figure 4Fuzzy K-partite clustering algorithm.
Figure 5The highest degree of molecular function with important protein.
Figure 6The highest degree of cellular component with important protein.
Figure 7The highest degree of biological process with important protein.
Figure 8Bipartite graph of important protein-molecular function.
Figure 9Bipartite graph of important protein-cellular component.
Figure 10Bipartite graph of important protein-biological process.
Maximum number of clusters for each type of GO.
| Maximum cluster | Number of clusters | ||
|---|---|---|---|
| Molecular function | Cellular component | Biological process | |
| Protein | 4 | 3 | 7 |
| GO | 6 | 6 | 27 |
Figure 11The mean IFNG expression in the SEVERE and MILD-HC groups was significantly different (p ≤ 0.01). It can be seen in the image that IFNG is downregulated that inhibits IFNG synthesis.
Figure 12The mean TBK1 expression in the SEVERE and MILD-HC groups not significantly different (p ≤ 0.01).
Figure 13PPI involved in the interferon response obtained from the STRING database with an interaction confidence score of 0.900.
GO terms associated with cytokines significant to COVID-19 cytokine storm.
| GO type | GO term | Exist in the resulting cluster |
|---|---|---|
| Molecular function | 1 Cytokine activity | Yes |
| 2 Growth factor activity | Yes | |
|
| ||
| Cellular component | 1 Extracellular space | Yes |
| 2 Extracellular region | Yes | |
|
| ||
| Biological process | 1 Immune response | No |
| 2 Cytokine-mediated signaling pathway | Yes | |
| 3 Signal transduction | No | |
| 4 Cellular response to lipopolysaccharide | Yes | |
| 5 Inflammatory response | Yes | |
| 6 Positive regulation of cell proliferation | No | |
| 7 Positive regulation of transcription by RNA polymerase II | No | |
| 8 Humoral immune response | Yes | |
| 9 Positive regulation of gene expression | Yes | |
| 10 Positive regulation of tyrosine phosphorylation of STAT protein | Yes | |
| 11 Positive regulation of DNA-binding transcription factor activity | Yes | |
| 12 Cell-cell signaling | No | |
| 13 MAPK cascade | Yes | |
| 14 Negative regulation of the apoptotic process | Yes | |
Enriched data from WikiPathway 2021.
| Term |
| Adjusted | Genes |
|---|---|---|---|
| Type I interferon induction and signaling during SARS-CoV-2 infection WP4868 | 2,88 | 4,00 | TBK1; OAS1; IRF3; STAT1; OAS2; STAT2; IRF7; TYK2; JAK1; IFNAR1 |
| Immune response to | 9,67 | 6,72 | OAS1; STAT1; STAT2; MX1; TYK2; IFIT1; IFIT3; JAK1; IFNAR1 |
| Host-pathogen interaction of human coronaviruses-interferon induction WP4880 | 4,54 | 2,10 | TBK1; OAS1; IRF3; STAT1; OAS2; STAT2; TYK2; JAK1; IFNAR1 |
| SARS-CoV-2 innate immunity evasion and cell-specific immune response WP5039 | 4,29 | 1,49 | IL6; TBK1; IRF3; STAT1; STAT2; MX1; IRF7; JAK1; IFNAR1 |
| Hepatitis B infection WP4666 | 8,24 | 2,29 | IL6; TBK1; IRF3; STAT1; STAT2; STAT3; IRF7; TYK2; JAK1; IFNAR1 |
| SARS coronavirus and innate immunity WP4912 | 7,92 | 1,84 | TBK1; IRF3; STAT1; STAT2; TYK2; JAK1; IFNAR1 |
| Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341 | 2,04 | 4,06 | IL6; RSAD2; STAT1; OAS2; STAT2; ISG15; TYK2; JAK1 |
| IL-10 anti-inflammatory signaling pathway WP4495 | 4,59 | 7,97 | IL6; STAT1; STAT2; STAT3; JAK1 |
| Type II interferon signaling (IFNG) WP619 | 9,95 | 1,54 | OAS1; STAT1; STAT2; IFI6; ISG15; JAK1 |
| Interferon type I signaling pathways WP585 | 1,09 | 1,52 | STAT1; STAT2; STAT3; TYK2; JAK1; IFNAR1 |
| Type III interferon signaling WP2113 | 1,52 | 1,92 | STAT1; STAT2; TYK2; JAK1 |
| Overview of interferon-mediated signaling pathway WP4558 | 2,48 | 2,88 | STAT1; STAT2; TYK2; JAK1; IFNAR1 |
| IL-6 signaling pathway WP364 | 5,47 | 5,84 | IL6; STAT1; STAT3; TYK2; JAK1 |
| Toll-like receptor signaling pathway WP75 | 5,88 | 5,84 | IL6; TBK1; IRF3; STAT1; IRF7; IFNAR1 |
| Regulation of toll-like receptor signaling pathway WP1449 | 3,62 | 3,35 | IL6; TBK1; IRF3; STAT1; IRF7; IFNAR1 |
| Cytosolic DNA-sensing pathway WP4655 | 9,61 | 8,35 | IL6; TBK1; IRF3; IRF7; ISG15 |
| TLR4 signaling and tolerance WP3851 | 1,47 | 1,20 | IL6; TBK1; IRF3; IRF7 |
| Interleukin-11 signaling pathway WP2332 | 9,62 | 7,43 | STAT1; STAT3; TYK2; JAK1 |
| Thymic stromal lymphoPoietin (TSLP) signaling pathway WP2203 | 1,26 | 9,23 | IL6; STAT1; STAT3; JAK1 |
| IL-4 signaling pathway WP395 | 2,23 | 1,55 | STAT1; STAT3; TYK2; JAK1 |
The expression level of healthy control, mild, and severe COVID-19 patients. Note: Values marked with an asterisk are not significantly different (p > 0.05).
| ID GENE | HC mean ( | MILD mean ( | SEVERE mean ( |
| Gene regulation in patient (up/down-regulated) |
|---|---|---|---|---|---|
| IFNAR1 | 6.963 ± 0.313 | 8.961 ± 0.282∗ | 9.660 ± 0.305∗ | ≤0.01 | Up |
| IFI6 | 7.739 ± 0.228 | 10.569 ± 0.739∗ | 10.461 ± 0.505∗ | ≤0.01 | Up |
| IRF7 | 6.886 ± 0.481 | 5.796 ± 0.102 | 4.985 ± 0.376 | ≤0.01 | Down |
| IRF3 | 9.699 ± 0.762 | 8.074 ± 0.288∗ | 7.713 ± 0.274∗ | ≤0.01 | Down |
| IFIT1 | 3.373 ± 0.247 | 5.743 ± 0.565∗ | 5.214 ± 0.752∗ | ≤0.01 | Up |
| IFIT3 | 2.894 ± 0.286 | 4.387 ± 0.969∗ | 4.699 ± 0.769∗ | ≤0.01 | Up |
| IFNA6 | 3.140 ± 0.230 | 5.424 ± 0.272∗ | 5.731 ± 1.114∗ | ≤0.01 | Up |
| IFNB1 | 2.970 ± 1.208∗ | 3.894 ± 0.461∗ | 6.065 ± 0.244 | ≤0.01 | Up |
| IFNG | 11.731 ± 1.069∗ | 9.729 ± 0.709∗ | 8.273 ± 1.088 | ≤0.01 | Down |